Sichuan Omnis Pharmaceutical Co., Ltd. Company Profile,Sichuan Omnis Pharmaceutical Co., Ltd. Essential Information

Company Profile

Our Company Our Business

Year Established : 2005

Total Assets(USD) : More than 99,999,999

Total Number of Staff : more than 1000

Main Competitive Advantages : International Approvals/Standards,Experienced R&D Staff,Delivery Term,Production Capacity,Large Product Line,Contract Manufacturing (CRO,CMO),Small Orders Accepted,Reputation,Quality Service

Other Competitive Advantages : Chengdu Baiyu Pharmaceutical Co., Ltd High quality-CDMO trusted partner Our 4 Factories •#1 Wenjiang •104667㎡ •#2 Wenjiang •20000㎡ •#3 Yuechi •130000㎡ •#4 CDHT •53333㎡ Quality by Design—— Focusing on the conception of "intelligent, economic and sustainable” , we hired experienced talents from Germany designed manufacturing facilities for, pursuing internationally accredited manufacturing system that meets the requirements of US FDA, EMA, and NMPA. Intelligent management with automatic production, digitized process Baiyu provide CDMO service for: FDFs & APIs Primary & secondary packaging Warehousing Commercial scale, pilot scale, laboratory scale You are warmly welcomed to contact us for business cooperation. CDMO Service Undertaking： Dosage Form Production Lines Annual Capacity Injection 8 650,000,000 Oral Solid 3 700,000,000 API & Intermediates 3 8,000 Kg TCM Extraction 2 5,000,000 Kg

Patents and Copyrights : Ginkgolide injection

Business Type : Trading Company,Service Provider,Manufacturer

R&D Capacity : OEM,Own Brand

Annual Turnover(USD) : More than 99,999,999

Main Sales Markets : North America,Central/South America,Western Europe,Eastern Europe,Australasia,Asia,Middle East,Africa

Product Range : Commercialized Products: API:_Edaravone FDFs: (freeze-dried powder injection)_Enoxaparin sodium, Pantoprazole sodium, Lansoprazole, Clindamycin phosphate, Azithromycin; (Liquid injection)_Ginkgolide injection, Ambroxol hydrocholride injection, Doxofylline injection. Under development:API_Rivaroxaban, Apixaban, Etoricoxib, Pramipexole dihydrochloride, Esomeprazole sodium, Dimethyl fumarate, Tolvaptan, Aprepitant, Ticagrelor, Apremilast, Dabigatran etexilate, Tofacitinib citrate, Tigecycline, Parecoxib sodium, Levetiracetam; FDFs: (freeze-dried powder injection)_Esomeprazole sodium,Tigecycline, Parecoxib sodium; Tablet: Rivaroxaban, Apixaban, Etoricoxib, Pramipexole dihydrochloride, Tolvaptan, Ticagrelor, Apremilast, Tofacitinib citrate, Levetiracetam; Capsule_ Dimethyl fumarate, Aprepitant, Dabigatran etexilate PPE: KN95, Disposable Medical Mask, FFP3, FFP2, Type IIR

Send Inquiry

Sichuan Omnis Pharmaceutical Co., Ltd.
Contact Person : Chen Chunyan
Tel: Click to View
Fax: --

A leading pharmaceutical company engaged in R&D, manufacturing and marketing of high quality medicinal products with special focus on CVS/CNS areas. Our manufacturing sites comply with EU/FDA/China GMP.

Ginkgolide injection is a global innovative herbal medicinal product of its kind for treatment of mild-moderate cerebral infarction. Other generic products are Enoxaparin sodium injection, pantoprazole sodium for injection, etc. Over 20 generic drugs are under development.

We also provide contract manufacture service of liquid injectables, lyophilized, tablets and capsules and cooperate with firms to introduce high-end pharmaceutical products into Chinese market.Baiyu are open to any business cooperation that can bring benefits to both sides.

In 2020, Baiyu Medical Supplies is founded and provide high quality of Personal Protective Equipment to again COVID-19, and relevant products(KN95, Disposable Medical mask, FFP3, FFP2, Type IIR) have launched around the whole world.

Company Profile of Sichuan Omnis Pharmaceutical Co., Ltd.

Company Profile